US 10683362
Recombinant immunotoxin targeting mesothelin
granted A61KA61K39/00A61K39/001168
Quick answer
US patent 10683362 (Recombinant immunotoxin targeting mesothelin) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K39/00, A61K39/001168, A61K47/6829, A61K47/6851